Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Interaction Map Network Comparison Type Rank Gene red Filtered green network_comparison
Results: HTML CSV LaTeX Showing element 594 to 643 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 100 kda subunit (cpsf 100 kda subunit) (fragment). [source:swissprot;acc:q9p2i0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
268\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
24473.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20127.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.21593\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 160 kda subunit (cpsf 160 kda subunit). [source:swissprot;acc:q10570]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
266\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
24806.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20369.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.21782\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 73 kda subunit (cpsf 73 kda subunit). [source:swissprot;acc:q9ukf6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
23422.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
19380.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20857\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cleavage stimulation factor subunit 3; cleavage stimulation factor, 3' pre-rna, subunit 3, 77kd. [source:refseq;acc:nm\_001326]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
294\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
22515.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
18702.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20387\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cleavage stimulation factor, 50 kda subunit (cstf 50 kda subunit) (cf-1 50 kda subunit). [source:swissprot;acc:q05048]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3129\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cleavage stimulation factor, 64 kda subunit (cstf 64 kda subunit) (cf-1 64 kda subunit). [source:swissprot;acc:p33240]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
552\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
15427.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13572.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13663\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cleft lip and palate associated transmembrane protein 1. [source:refseq;acc:nm\_001294]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2337\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5123.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5350.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04428\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
clll6 protein. [source:refseq;acc:nm\_020456]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3028\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
coactosin-like protein. [source:swissprot;acc:q14019]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1952\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5888.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6245.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06073\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
coatomer alpha subunit (alpha-coat protein) (alpha-cop) (hepcop) (hep-cop) [contains: xenin (xenopsin-related peptide); proxenin]. [source:swissprot;acc:p53621]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1718\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9720.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9099.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06831\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
coatomer beta subunit (beta-coat protein) (beta-cop). [source:swissprot;acc:p53618]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1335\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10430.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9656.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08014\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
coatomer beta' subunit (beta'-coat protein) (beta'-cop) (p102). [source:swissprot;acc:p35606]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1500\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
10075.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9377.75\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0744\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
coatomer delta subunit (delta-coat protein) (delta-cop) (archain). [source:swissprot;acc:p48444]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1503\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
coatomer epsilon subunit (epsilon-coat protein) (epsilon-cop). [source:swissprot;acc:o14579]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2352\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8493.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8135.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
coatomer gamma subunit (gamma-coat protein) (gamma-cop). [source:swissprot;acc:q9y678]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1501\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
10075.5\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9377.75\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0744\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
coatomer zeta-1 subunit (zeta-1 coat protein) (zeta-1 cop) (cgi-120) (hspc181). [source:swissprot;acc:q9y3c3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1502\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
coatomer zeta-2 subunit (zeta-2 coat protein) (zeta-2 cop). [source:swissprot;acc:q9p299]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1505\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cofilin, muscle isoform (cofilin 2). [source:swissprot;acc:q9y281]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1946\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6230.21\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6608.64\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06074\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cofilin, non-muscle isoform (18 kda phosphoprotein) (p18). [source:swissprot;acc:p23528]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1945\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
collagen alpha 3(iv) chain precursor (goodpasture antigen). [source:swissprot;acc:q01955]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1463\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5672.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6103.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07611\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
collagen alpha 5(iv) chain precursor. [source:swissprot;acc:p29400]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1457\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5672.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6103.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07612\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
collectin sub-family member 12 isoform i; scavenger receptor with c-type lectin; collectin placenta 1; scavenger receptor class a, member 4. [source:refseq;acc:nm\_130386]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2881\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
colorectal mutant cancer protein (mcc protein). [source:swissprot;acc:p23508]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1810\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6520.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6946.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06532\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
complement component 1, q subcomponent binding protein, mitochondrial precursor (glycoprotein gc1qbp) (gc1q-r protein) (hyaluronan-binding protein 1) (p32) (p33). [source:swissprot;acc:q07021]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2198\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6344.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6657.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04944\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
complement component c6 precursor. [source:swissprot;acc:p13671]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3199\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
complement component c7 precursor. [source:swissprot;acc:p10643]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3064\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
complement component c8 alpha chain precursor. [source:swissprot;acc:p07357]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2886\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
complement component c8 beta chain precursor. [source:swissprot;acc:p07358]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3207\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
complement component c9 precursor. [source:swissprot;acc:p02748]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3057\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cone-rod homeobox protein. [source:swissprot;acc:o43186]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2401\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5694.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5916.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03912\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
connective tissue growth factor precursor (hypertrophic chondrocyte- specific protein 24). [source:swissprot;acc:p29279]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3040\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
connective tissue growth factor-like protein precursor (ctgf-l) (wnt1 inducible signaling pathway protein 2) (wisp-2) (connective tissue growth factor-related protein 58). [source:swissprot;acc:o76076]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3188\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 1. [source:swissprot;acc:q8wtw3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2836\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 2 (low density lipoprotein receptor defect c-complementing protein). [source:swissprot;acc:q14746]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2216\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5910.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6199.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04893\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 3 (vesicle docking protein sec34 homolog) (p94). [source:swissprot;acc:q96jb2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1779\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5386.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5744.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06656\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 6. [source:swissprot;acc:q9y2v7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2453\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6931.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7152.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03197\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 7. [source:swissprot;acc:p83436]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1933\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10300\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9701.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06171\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
conserved oligomeric golgi complex subunit 5 (13s golgi transport complex 90 kda subunit) (gtc-90) (golgi transport complex 1). [source:swissprot;acc:q9up83]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2682\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5358.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5383.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00478\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cop-coated vesicle membrane protein p24 precursor (p24a). [source:swissprot;acc:q15363]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3168\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cop9 complex subunit 4; likely ortholog of mouse cop9 (constitutive photomorphogenic), subunit 4 (arabidopsis); cop9 (constitutive photomorphogenic, arabidopsis, homolog) subunit 4. [source:refseq;acc:nm\_016129]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1975\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6988.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7406.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05985\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cop9 constitutive photomorphogenic homolog subunit 3; cop9 complex subunit 3; jab1-containing signalosome subunit 3. [source:refseq;acc:nm\_003653]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
264\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4987.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4094.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.2181\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cop9 constitutive photomorphogenic homolog subunit 5; jun activation domain-binding protein. [source:refseq;acc:nm\_006837]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2330\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6773.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7075.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04456\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cop9 signalosome complex subunit 1 (g protein pathway suppressor 1) (gps1 protein) (mfh protein). [source:swissprot;acc:q13098]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2827\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cop9 signalosome complex subunit 2 (signalosome subunit 2) (sgn2) (thyroid receptor interacting protein 15) (trip15). [source:swissprot;acc:q15647]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2841\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cop9 subunit 6 (mov34 homolog, 34 kd). [source:refseq;acc:nm\_006833]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2324\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6773.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7075.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04456\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
copper-transporting atpase 1 (ec 3.6.3.4) (copper pump 1) (menkes disease-associated protein). [source:swissprot;acc:q04656]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1752\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5941.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6339.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0671\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
copper-transporting atpase 2 (ec 3.6.3.4) (copper pump 2) (wilson disease-associated protein). [source:swissprot;acc:p35670]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1754\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5941.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6340.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06707\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
coproporphyrinogen iii oxidase, mitochondrial precursor (ec 1.3.3.3) (coproporphyrinogenase) (coprogen oxidase) (cox). [source:swissprot;acc:p36551]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2734\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7913.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7939.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00332\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
core-binding factor, beta subunit (cbf-beta) (polyomavirus enhancer binding protein 2 beta subunit) (pebp2-beta) (pea2-beta) (sl3-3 enhancer factor 1 beta subunit) (sl3/akv core-binding factor beta subunit). [source:swissprot;acc:q13951]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3183\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cox15 homolog isoform 2 precursor; cytochrome c oxidase subunit 15; cytochrome c oxidase assembly protein. [source:refseq;acc:nm\_004376]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
932\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5638.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6194.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09853\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/